Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026)
Alnylam Pharmaceuticals' (ALNY) quarterly Change in Inventory came in at -$280000.0 in Q2 2026, up 97.49% YoY from -$141781.2 in Q2 2025, and down 108.42% on a QoQ basis from $3.3 million in Q1 2026.
Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 9 years of Change in Inventory data on file, last reported at -$280000.0 in Q2 2026.
- Quarterly Change in Inventory rose 97.49% year-over-year to -$280000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.9 million (up 149.43% YoY) and the FY2025 annual result came in at -$8.5 million, up 37.65% from the prior year.
- Change in Inventory declined to -$280000.0 in Q2 2026, from $3.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $19.0 million in Q4 2022 to a low of -$12.0 million in Q4 2023.
- A 5-year average of -$180611.1 and a median of -$1.4 million in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 1732.63% in 2025, down 28150.0% in 2025.
- Tracing ALNY's Change in Inventory over 5 years: stood at $19.0 million in 2022, then tumbled by 163.18% to -$12.0 million in 2023, then surged by 92.92% to -$849000.0 in 2024, then soared by 1732.63% to $13.9 million in 2025, then sank by 102.02% to -$280000.0 in 2026.
- The last three Change in Inventory figures came in at -$280000.0 (Q2 2026), $3.3 million (Q1 2026), and $13.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -280,000.00 |
| Jun 30, 2026 | -280,000.00 |
| Mar 31, 2026 | 3.32 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 13.86 Mn |
| Dec 31, 2025 | 13.86 Mn |
| Sep 30, 2025 | -4.98 Mn |
| Sep 30, 2025 | -4.98 Mn |
| Jun 30, 2025 | -11.14 Mn |
| Jun 30, 2025 | -11.14 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -849,000.00 |
| Dec 31, 2024 | -849,000.00 |
| Sep 30, 2024 | -5.93 Mn |
| Sep 30, 2024 | -5.93 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Mar 31, 2024 | -22,000.00 |
| Mar 31, 2024 | -22,000.00 |